Schematic illustration of the outcomes of a second infusion of CD19 CAR T cells in patients who failed to adequately respond to the first infusion. The addition of Cy-Flu lymphodepletion before the first infusion and an increased CAR T-cell dose for the second infusion are independently associated with durable responses.